Xin Li

Xin Li serves as a Guest Researcher in the Sørensen Group at the Center for Integrative Organ Disease (iMED), University of Copenhagen, based at the Biotech Research & Innovation Centre (BRIC) in Copenhagen, Denmark. Contactable via xin.li@bric.ku.dk and +4535332020, Li contributes to interdisciplinary biomedical research within a leading European academic institution.

Research focuses on molecular mechanisms of genome integrity, oncogenesis, and therapeutic innovation. Key areas include tumor-suppressive functions of myosin proteins, antibody-drug conjugate development for precision payload delivery, and CRISPR-based genomic variant analysis. This work bridges fundamental cell biology with translational applications in cancer and genetic disorders, emphasizing interdisciplinary approaches across molecular oncology and pharmacology.

Recent publications reveal a cohesive trajectory in targeting disease mechanisms through advanced molecular tools, with increasing emphasis on therapeutic translation from basic discoveries. The research integrates structural biology, genetic engineering, and drug delivery systems to address unmet clinical needs in oncology and genomic medicine.

No scientific awards were documented in the provided information.

No details regarding student advising, supervisory roles, or research grant funding were specified in the available text.

Li operates within the Sørensen Group at iMED, a collaborative research environment focused on integrative disease mechanisms and therapeutic development. This group leverages BRIC's infrastructure for cutting-edge studies in genome stability, molecular oncology, and novel biopharmaceutical platforms.